Skip to content
10-K/A

Annual Report

IRADIMED CORP IRMD

0001558370-25-011853

← back to feed
Filed
Sep 3, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Aug 31, 2025 12.72M sh
Shares Diluted restated FY 2024 · Dec 31, 2024 12.78M sh
Shares Diluted FY 2024 · Dec 31, 2023 12.72M sh
Dividends Paid restated FY 2024 · Dec 31, 2024 $13.68M
Dividends Paid FY 2024 · Dec 31, 2023 $13.22M
Capex restated FY 2024 · Dec 31, 2024 $8.01M
Capex FY 2024 · Dec 31, 2023 $7.44M
Operating Cash Flow restated FY 2024 · Dec 31, 2024 $25.62M
Operating Cash Flow FY 2024 · Dec 31, 2023 $13.47M
Cash And Equivalents restated FY 2024 · Dec 31, 2024 $52.23M
Cash And Equivalents FY 2024 · Dec 31, 2023 $49.76M
Stockholders Equity restated FY 2024 · Dec 31, 2024 $86.82M
Stockholders Equity restated FY 2024 · Dec 31, 2023 $71.42M
Stockholders Equity FY 2024 · Dec 31, 2022 $73.67M
Current Liabilities restated FY 2024 · Dec 31, 2024 $8.51M
Current Liabilities FY 2024 · Dec 31, 2023 $16.33M
Total Liabilities restated FY 2024 · Dec 31, 2024 $11.51M
Total Liabilities FY 2024 · Dec 31, 2023 $20.74M
Current Assets restated FY 2024 · Dec 31, 2024 $75.24M
Current Assets FY 2024 · Dec 31, 2023 $76M
Total Assets restated FY 2024 · Dec 31, 2024 $98.33M
Total Assets FY 2024 · Dec 31, 2023 $92.16M
Eps Diluted FY 2024 · Dec 31, 2024 $1.50
Eps Diluted FY 2024 · Dec 31, 2023 $1.35
Eps Basic FY 2024 · Dec 31, 2024 $1.52
Eps Basic FY 2024 · Dec 31, 2023 $1.36
Sga Expense restated FY 2024 · Dec 31, 2024 $15.94M
Sga Expense FY 2024 · Dec 31, 2023 $15.12M
Rd Expense restated FY 2024 · Dec 31, 2024 $2.83M
Rd Expense FY 2024 · Dec 31, 2023 $2.86M
Net Income restated FY 2024 · Dec 31, 2024 $19.23M
Net Income FY 2024 · Dec 31, 2023 $17.19M
Operating Income restated FY 2024 · Dec 31, 2024 $21.96M
Operating Income FY 2024 · Dec 31, 2023 $20.04M
Gross Profit restated FY 2024 · Dec 31, 2024 $56.35M
Gross Profit FY 2024 · Dec 31, 2023 $50.16M
Cost Of Revenue restated FY 2024 · Dec 31, 2024 $16.89M
Cost Of Revenue FY 2024 · Dec 31, 2023 $15.4M
Revenue restated FY 2024 · Dec 31, 2024 $73.24M
Revenue FY 2024 · Dec 31, 2023 $65.56M